ITGAX and acute myeloid leukemia: THP-1 AML (effector) cells were differentiated into phagocytic cells by treatment with PMA, as determined by flow cytometric analysis to monitor the expression of CD11b, CD11c, and TIM-3 (Supplementary Fig. 3A).